These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18451017)

  • 1. Psychiatric opinion and antipsychotic selection in the management of schizophrenia.
    Arbuckle MR; Gameroff MJ; Marcus SC; West JC; Wilk J; Olfson M
    Psychiatr Serv; 2008 May; 59(5):561-5. PubMed ID: 18451017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding or switching antipsychotic medications in treatment-refractory schizophrenia.
    Kreyenbuhl J; Marcus SC; West JC; Wilk J; Olfson M
    Psychiatr Serv; 2007 Jul; 58(7):983-90. PubMed ID: 17602016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.
    Young GJ; Mohr DC; Meterko M; Seibert MN; McGlynn G
    Psychiatr Serv; 2006 Jan; 57(1):130-2. PubMed ID: 16399975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
    Kulkarni J; Reeve-Parker K
    Australas Psychiatry; 2015 Jun; 23(3):258-64. PubMed ID: 25783668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
    Altamura AC; Armadoros D; Jaeger M; Kernish R; Locklear J; Volz HP
    Curr Med Res Opin; 2008 Aug; 24(8):2271-82. PubMed ID: 18588748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatrists' psychotropic drug prescription preferences for themselves or their family members.
    Latas M; Stojkovic T; Ralic T; Milovanovic S; Jasovic-Gasic M
    Psychiatr Danub; 2012 Jun; 24(2):182-7. PubMed ID: 22706417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia trial participation: perceived inclusion barriers and beliefs about antipsychotics.
    Ghio L; Natta W; Barbato A; Marcenaro M; Gotelli S; Jones PB; Parabiaghi A
    Pharmacopsychiatry; 2011 Jun; 44(4):123-8. PubMed ID: 21710401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia.
    Green MF; Barnes TR; Danion JM; Gallhofer B; Meltzer HY; Pantelis C
    Schizophr Res; 2005 May; 74(2-3):253-61. PubMed ID: 15722004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PRESCRIPTION PATTERNS IN THE TREATMENT OF SCHIZOPHRENIA].
    Leiderman EA; Lorenzo L
    Vertex; 2015; 26(119):11-6. PubMed ID: 26323108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.
    Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ;
    Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment.
    Markowitz MA; Levitan BS; Mohamed AF; Johnson FR; Bridges JF; Alphs L; Citrome L
    Psychiatr Serv; 2014 Sep; 65(9):1133-9. PubMed ID: 24828964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.